SlideShare ist ein Scribd-Unternehmen logo
1 von 50
Downloaden Sie, um offline zu lesen
Swine Flu 2017
CONTENT
What is Swine flu?
Symptoms of Swine flu?
Mode of Transmission ?
Period of Communicability?
Incubation Period?
Prevention of Swine flu
TAKE HOME MESSAGE
WHAT IS SWINE FLU?
It is a respiratory disease caused by H1 N1
Type A Influenza Virus.
It is like ordinary flu.
The Swine flu was initially seen in humans in
Mexico in 2009, where the strand of the
particular virus was a marriage of 3 types of
strands.
WHAT IS SWINE FLU?
WHAT IS SWINE FLU?
WHAT IS SWINE FLU?
 The major reason of its world wide spread is
the lack of immunity against the virus in a
large population.
WHO declares swine flu as pandemic on 11
June 2009.
SYMPTOMS OF SWINE FLU?
SYMPTOMS OF SWINE FLU?
 Fever
 Sore Throat
 Cough
 Headache
 Body ache
 Lethargy
 Diarrhoea and Vomiting
Mode of Transmission?
Mode of Transmission?
 Cough and Sneezing by Infected Indl
 Virus deposited on any Surface
 Healthy indl touches the contaminated surface
 Healthy Indl touches his Eyes, Nose or Mouth
 Healthy Indl becomes infected
Period of Communicability?
1 Day 7 Days
Incubation Period?
2 Days
(1-4 Days)
High Risk Group
 Children with mild illness
but with predisposing risk factors.
 Pregnant women;
 Persons aged 65 years or older;
 Patients with lung diseases,
heart disease, liver disease, kidney disease, blood
disorders, diabetes, neurological disorders, cancer and
HIV/AIDS;
 Patients on long term cortisone therapy.
Warning Signals in Adults ?
 Breathlessness,
 chest pain,
 drowsiness,
 fall in blood pressure,
 sputum mixed with blood,
 bluish discolouration of nails;
 Confusion
Warning Signals in Children
(Red Flag Signs) ?
 Somnolence,
 high and persistent fever,
 inability to feed well,
 convulsions,
 shortness of breath,
 difficulty in breathing,
 Inconsolable cry, etc.
Prevention and control
 In order to prevent and contain outbreak of
Influenza virus the following guidelines for
screening, testing and isolation are to be followed:
 At first all individuals seeking consultations for flu
like symptoms should be screened at healthcare
facilities both Government and private or examined
by a doctor and these will be categorized as under:
Category A
 Patients with mild fever plus cough / sore throat
with or without bodyache, headache, diarrhoea and
vomiting will be categorized as Category-A.
 They do not require Oseltamivir and should be
treated for the symptoms mentioned above. The
patients should be monitored for their progress and
reassessed at 24 to 48 hours by the doctor.
 No testing of the patient for Influenza is required.
 Patients should confine themselves at home and
avoid mixing up with public and high risk members
in the family.
Category B
 (i) In addition to all the signs and symptoms
mentioned under Category-A, if the patient has high
grade fever and severe sore throat, may require
home isolation and Oseltamivir;
 (ii) In addition to all the signs and symptoms
mentioned under Category-A, individuals having
one or more of the following high risk conditions
shall be treated with Oseltamivir:
Category B
 Children with mild illness but with predisposing risk
factors.
 Pregnant women;
 Persons aged 65 years or older;
 Patients with lung diseases, heart disease, liver
disease, kidney disease, blood disorders, diabetes,
neurological disorders, cancer and HIV/AIDS;
 Patients on long term cortisone therapy
Category B
 No tests for Influenza is required for Category-B (i)
and (ii).
 All patients of Category-B (i) and (ii) should confine
themselves at home and avoid mixing with public
and high risk members in the family.
 Broad Spectrum antibiotics as per the Guideline for
Community-acquired pneumonia (CAP) may be
prescribed.
Category C
 In addition to the above signs and symptoms of
Category-A and B, if the patient has one or more of
the following:
 Breathlessness, chest pain, drowsiness, fall in blood
pressure, sputum mixed with blood, bluish
discolouration of nails;
Category C
 Children with influenza like illness who had a severe
disease as manifested by the red flag signs
(Somnolence, high and persistent fever, inability to
feed well, convulsions, shortness of breath,
difficulty in breathing, etc).
 Worsening of underlying chronic conditions.
 All these patients mentioned above in Category-C
require testing, immediate hospitalization and
treatment.
Prevention
रोकथाम के उपाय
क्या करैं
१. ख ांसते य छ ांकते समय अपने
मांह व न क को टिश्यू य रूम ल से
कवर करैं |
२. अपनी आांख, न क य मांह को
छू ने से पहले ह थों को अच्छ तरह
स बन से धोयें |
३. बीम र व्यक्तत से दूरी बन ये
रखें |
४. कोई भी तकलीफ होने पर
डॉतिर की सल ह अवश्य लें |
५. खूब प नी पीयें, पोषक भोजन
ख यें और भरपूर नीांद लें |
क्या नह ीं करैं
१.ह थ ममल ने, गले ममलने और
चम्बन लेने से बचें |
२. भीड़ व ले स्थ नों पर ज ने से
बचें |
३. फ्लू रोगी के अधधक ननकि न
ज यें |
४. जह ाँ तक हो सके अपनी आाँख,
न क य मांह को न छयें |
५. अपने ह थों पर ख ांसे य छ कें
नहीां
६. ड तिर की सल ह के बबन
कोई दव ई न लें |
Vaccine
 While declaring the Pandemic to be over in August
2010, WHO conveyed that Pandemic Influenza A
(HINI) virus that caused Pandemic [2009-2010]
would circulate as Seasonal Influenza virus and
would continue to do so for years to come.
 WHO recommended vaccine only for High Risk Group
 Ministry of Health and Family Welfare recommends
the trivalent inactivated influenza vaccine.
Vaccine
 The ICMR has recommended on the following
Seasonal Influenza vaccine composition, for the
period 2017-2018. The recommended Trivalent
vaccine should have:
 an A/Michigan/45/2015 (H1N1)pdm09-like virus
 an A/Hong Kong/4801/2014 (H3N2) – like virus
 a B/Brisbane/60/2008-like virus
Vaccine
 The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.
Vaccine
 The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.
Limitations of the Influenza
Vaccination
 Influenza vaccination is most effective when
circulating viruses are well-matched with vaccine
viruses.
 Even with appropriate matching, efficacy of vaccine
may be about 70% to 80%.
 In case the locally circulating virus is different from
vaccine virus recommended by WHO, it may be
partially effective or not be effective at all.
 Hence, vaccine should not give a false sense of
security.
High Risk Groups for whom
vaccine is recommended by WHO
 Health Care workers, working in hospital / institutional
settings (doctors, nurses, paramedics) with likelihood
of exposure to Influenza virus
 Young children
 Pregnant women;
 Persons aged 65 years or older;
 Patients with Comorbidity
 Patients with compromised immunity
USE OF MASKS
 There are two types of masks which are recommended
for various categories of personnel depending upon the
work environment;
1. Triple layer surgical mask 2. N 95 Respirator
 Change the mask after six hours or as soon as they
become wet.
 Disposable masks are never to be reused and should be
disposed off.
 Never touch the potentially infected outer surface of
the mask while removing it.
USE OF MASKS
 There is no scientific evidence to show health benefit of
using masks for members of public. In fact erroneous
use of masks or continuous use of a disposable mask
for longer than 6 hours or repeated use of same mask
may actually increase risk of infection further.
 In the hospital setting used masks should be disposed
off in the identified infectious waste disposal
bag/container.
 In community settings, it may be disposed off either by
burning or deep burial.
Triple layer surgical mask
 Suspect/ probable/confirmed cases of influenza.
 The care provider in home care settings
 Close family contacts of such cases undergoing home
care should also use Triple layer surgical mask.
 All medical personnel (Doctor, nursing and paramedical
staff) would use Disposable Triple layer surgical mask
while interacting with patients in screening area.
 All patients, Medical and nursing staff in the isolation
wards.
Triple layer surgical mask
 Personnel involved in handling dead bodies of
suspect/confirmed cases (Mortuary)
 Ambulance Staff including driver.
 Doctors /Private practitioners with other health
workers in screening centres / general practice
 Health workers involved in community surveillance
 Security personnel working in an infected/ potentially
infected area for example Influenza ward in a hospital,
screening centre etc.
N 95 Respirator
 Staff involved in any aerosol generating procedures
like suction, intubation, nebulization, etc. they must
use N95 Respirator
 Medical personnel need to collect clinical samples from
patients.
 Medical personnel in ICU
 Medical personnel in laboratory
Tamiflu (Oseltamivir)
 Oseltamivir is the recommended drug for treatment.
Dose for treatment is as follows -
 By Weight:
 o For weight <15kg 30 mg BD for 5 days
 o 15-23kg 45 mg BD for 5 days
 o 24-<40kg 60 mg BD for 5 days
 o >40kg 75 mg BD for 5 days
Tamiflu (Oseltamivir)
 For infants:
 o < 3 months 12 mg BD for 5 days
 o 3-5 months 20 mg BD for 5 days
 o 6-11 months 25 mg BD for 5 days
 It is also available as syrup (12mg per ml)
Q 1. SWINE FLU IS CAUSED BY ?
A. BACTERIA
B. VIRUS
C. (FUNGUS
D. CONTAMINATED WATER
Q 1. SWINE FLU IS CAUSED BY ?
B. VIRUS
Q 2. SWINE FLU SPREAD
INCREASES IN ?
A. Winters
B. Summers
C. Rain
D. Spring
Q 2. SWINE FLU SPREAD
INCREASES IN ?
Winters & Rainy
season
Q3. DRUG USED IN SWINE FLU
TREATMENT?
A. AMIKACIN
B. TAMIFLU (OSELTAMIVIR)
C. CETRIZINE
D. GLICLAZIDE
Q3. DRUG USED IN SWINE FLU
TREATMENT ?
B. TAMIFLU
Q4. SYMPTOMS OF SWINE FLU ARE ?
A.Fever
B.Sore throat
C.Cough
D. Body ache
E. All of the above
Q4. SYMPTOMS OF SWINE FLU ARE ?
E. All of the above
Q5. What are the preventive
measures of Swine flu ?
A. Cover your cough and sneeze.
B. Wash your hands at regular interval.
C. Avoid touching your eye, nose and mouth
unnecessarily.
D. Keep safe distance from an infected
individual.
E. All of the above.
Q5. What are the preventive
measures of Swine flu ?
E. All of the above
TAKE HOME MESSAGE
Swine Flu 2017
Swine Flu 2017

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Malaria: Pathophysiology, Medical and Nursing Management
Malaria: Pathophysiology, Medical and Nursing ManagementMalaria: Pathophysiology, Medical and Nursing Management
Malaria: Pathophysiology, Medical and Nursing Management
 
Cholera in community health nursing
Cholera in community health nursingCholera in community health nursing
Cholera in community health nursing
 
Emergency & Disaster nursing
Emergency & Disaster nursingEmergency & Disaster nursing
Emergency & Disaster nursing
 
Immunization
ImmunizationImmunization
Immunization
 
Nursing care of patients with Hernia
Nursing care of patients with HerniaNursing care of patients with Hernia
Nursing care of patients with Hernia
 
Intravenous therapy
Intravenous therapyIntravenous therapy
Intravenous therapy
 
BCG ,DPT ,OPV
BCG ,DPT ,OPVBCG ,DPT ,OPV
BCG ,DPT ,OPV
 
Rabies: Considerations to Nursing
Rabies: Considerations to NursingRabies: Considerations to Nursing
Rabies: Considerations to Nursing
 
GEMC - Measles, Mumps, Rubella - for Nurses
GEMC - Measles, Mumps, Rubella - for NursesGEMC - Measles, Mumps, Rubella - for Nurses
GEMC - Measles, Mumps, Rubella - for Nurses
 
Cold chain
Cold chainCold chain
Cold chain
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
Disturbed sleeping pattern
Disturbed sleeping patternDisturbed sleeping pattern
Disturbed sleeping pattern
 
Nursing care patient with Chest tube ppt
Nursing care patient with Chest tube pptNursing care patient with Chest tube ppt
Nursing care patient with Chest tube ppt
 
Poisoning ppt
Poisoning pptPoisoning ppt
Poisoning ppt
 
Blood transfusions ppt
Blood transfusions pptBlood transfusions ppt
Blood transfusions ppt
 
Therapeutic nurse patient-relationship
Therapeutic nurse patient-relationshipTherapeutic nurse patient-relationship
Therapeutic nurse patient-relationship
 
Opv
OpvOpv
Opv
 
Disaster management and role of nurse
Disaster management and role of nurseDisaster management and role of nurse
Disaster management and role of nurse
 
Typhoid fever ppt.
Typhoid fever ppt.Typhoid fever ppt.
Typhoid fever ppt.
 
Measles
MeaslesMeasles
Measles
 

Ähnlich wie Swine Flu 2017

Introspecting into Swine flu: Current updates
Introspecting into Swine flu: Current updatesIntrospecting into Swine flu: Current updates
Introspecting into Swine flu: Current updatesArnab Nandy
 
Swine flu- Pandemic Influenza A (H1N1)
Swine flu- Pandemic Influenza A (H1N1)Swine flu- Pandemic Influenza A (H1N1)
Swine flu- Pandemic Influenza A (H1N1)Sumi Singh
 
What is influenza (also called flu)
What is influenza (also called flu) What is influenza (also called flu)
What is influenza (also called flu) sckrmc
 
Swine flue infection
Swine flue infectionSwine flue infection
Swine flue infectionmandar haval
 
Swine flu in pregnancy
Swine flu in pregnancySwine flu in pregnancy
Swine flu in pregnancydr.hafsa asim
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAMAHESWARI JAIKUMAR
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAMAHESWARI JAIKUMAR
 
2019 novel coronavirus(2019-n cov) outbreak preparedness
2019  novel coronavirus(2019-n cov) outbreak preparedness 2019  novel coronavirus(2019-n cov) outbreak preparedness
2019 novel coronavirus(2019-n cov) outbreak preparedness Sumi Nandwani
 
2019 novel coronavirus(2019-n cov) outbreak preparedness
2019  novel coronavirus(2019-n cov) outbreak preparedness 2019  novel coronavirus(2019-n cov) outbreak preparedness
2019 novel coronavirus(2019-n cov) outbreak preparedness Sumi Nandwani
 
H1 N1(Swine Flu) Infection Control Healthcare Setting043009
H1 N1(Swine Flu) Infection Control Healthcare Setting043009H1 N1(Swine Flu) Infection Control Healthcare Setting043009
H1 N1(Swine Flu) Infection Control Healthcare Setting043009State of Utah, Salt Lake City
 
SWINE FLU.ppt
SWINE FLU.pptSWINE FLU.ppt
SWINE FLU.pptBUDDYSMBD
 

Ähnlich wie Swine Flu 2017 (20)

Swine flu
Swine flu Swine flu
Swine flu
 
Swine Flu
Swine FluSwine Flu
Swine Flu
 
H1 N1
H1 N1H1 N1
H1 N1
 
Introspecting into Swine flu: Current updates
Introspecting into Swine flu: Current updatesIntrospecting into Swine flu: Current updates
Introspecting into Swine flu: Current updates
 
Swine flu- Pandemic Influenza A (H1N1)
Swine flu- Pandemic Influenza A (H1N1)Swine flu- Pandemic Influenza A (H1N1)
Swine flu- Pandemic Influenza A (H1N1)
 
Measles
MeaslesMeasles
Measles
 
What is influenza (also called flu)
What is influenza (also called flu) What is influenza (also called flu)
What is influenza (also called flu)
 
Swine flu
Swine fluSwine flu
Swine flu
 
H1 N1
H1 N1H1 N1
H1 N1
 
H1N1 Influenza
H1N1 InfluenzaH1N1 Influenza
H1N1 Influenza
 
Swine flue infection
Swine flue infectionSwine flue infection
Swine flue infection
 
Swine flu in pregnancy
Swine flu in pregnancySwine flu in pregnancy
Swine flu in pregnancy
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
 
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZAEPIDEMIOLOGY OF PANDEMIC INFLUENZA
EPIDEMIOLOGY OF PANDEMIC INFLUENZA
 
2019 novel coronavirus(2019-n cov) outbreak preparedness
2019  novel coronavirus(2019-n cov) outbreak preparedness 2019  novel coronavirus(2019-n cov) outbreak preparedness
2019 novel coronavirus(2019-n cov) outbreak preparedness
 
2019 novel coronavirus(2019-n cov) outbreak preparedness
2019  novel coronavirus(2019-n cov) outbreak preparedness 2019  novel coronavirus(2019-n cov) outbreak preparedness
2019 novel coronavirus(2019-n cov) outbreak preparedness
 
Swine Flu
Swine FluSwine Flu
Swine Flu
 
H1 N1(Swine Flu) Infection Control Healthcare Setting043009
H1 N1(Swine Flu) Infection Control Healthcare Setting043009H1 N1(Swine Flu) Infection Control Healthcare Setting043009
H1 N1(Swine Flu) Infection Control Healthcare Setting043009
 
S W I N E  F L U
S W I N E  F L US W I N E  F L U
S W I N E  F L U
 
SWINE FLU.ppt
SWINE FLU.pptSWINE FLU.ppt
SWINE FLU.ppt
 

Mehr von Drajay Tyagi

Swine flu hindi dr ajay tyagi md (psm)
Swine flu hindi dr ajay tyagi md (psm)Swine flu hindi dr ajay tyagi md (psm)
Swine flu hindi dr ajay tyagi md (psm)Drajay Tyagi
 
Leptospirosis- Dr Ajay Tyagi
Leptospirosis- Dr Ajay TyagiLeptospirosis- Dr Ajay Tyagi
Leptospirosis- Dr Ajay TyagiDrajay Tyagi
 
Diarrhoea, ar is & malnutrition dr ajay tyagi
Diarrhoea, ar is & malnutrition  dr ajay tyagiDiarrhoea, ar is & malnutrition  dr ajay tyagi
Diarrhoea, ar is & malnutrition dr ajay tyagiDrajay Tyagi
 
Operational research dr ajay tyagi
Operational research dr ajay tyagiOperational research dr ajay tyagi
Operational research dr ajay tyagiDrajay Tyagi
 
Motivation -Dr Ajay Tyagi 2011
Motivation -Dr Ajay Tyagi 2011Motivation -Dr Ajay Tyagi 2011
Motivation -Dr Ajay Tyagi 2011Drajay Tyagi
 
Diarrhoea prevention and control
Diarrhoea prevention and controlDiarrhoea prevention and control
Diarrhoea prevention and controlDrajay Tyagi
 

Mehr von Drajay Tyagi (7)

Swine flu hindi dr ajay tyagi md (psm)
Swine flu hindi dr ajay tyagi md (psm)Swine flu hindi dr ajay tyagi md (psm)
Swine flu hindi dr ajay tyagi md (psm)
 
Nostalgia 2003
Nostalgia 2003 Nostalgia 2003
Nostalgia 2003
 
Leptospirosis- Dr Ajay Tyagi
Leptospirosis- Dr Ajay TyagiLeptospirosis- Dr Ajay Tyagi
Leptospirosis- Dr Ajay Tyagi
 
Diarrhoea, ar is & malnutrition dr ajay tyagi
Diarrhoea, ar is & malnutrition  dr ajay tyagiDiarrhoea, ar is & malnutrition  dr ajay tyagi
Diarrhoea, ar is & malnutrition dr ajay tyagi
 
Operational research dr ajay tyagi
Operational research dr ajay tyagiOperational research dr ajay tyagi
Operational research dr ajay tyagi
 
Motivation -Dr Ajay Tyagi 2011
Motivation -Dr Ajay Tyagi 2011Motivation -Dr Ajay Tyagi 2011
Motivation -Dr Ajay Tyagi 2011
 
Diarrhoea prevention and control
Diarrhoea prevention and controlDiarrhoea prevention and control
Diarrhoea prevention and control
 

Kürzlich hochgeladen

Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learningNehaKewat
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxHanineHassan2
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYRMC
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdfDolisha Warbi
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....sharyurangari111
 
Pharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxPharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxCliniminds India
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxsandhulove46637
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxEMADABATHINI PRABHU TEJA
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal TutorNehaKewat
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfhezamzaki1
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
Understanding Warts and Moles: Differences, Types, and Common Locations
Understanding Warts and Moles: Differences, Types, and Common LocationsUnderstanding Warts and Moles: Differences, Types, and Common Locations
Understanding Warts and Moles: Differences, Types, and Common LocationsNeha Sharma
 

Kürzlich hochgeladen (20)

Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
EYE CANCER.pptx prepared by Neha kewat digital learning
EYE CANCER.pptx prepared by  Neha kewat digital learningEYE CANCER.pptx prepared by  Neha kewat digital learning
EYE CANCER.pptx prepared by Neha kewat digital learning
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
 
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
 
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
"ANATOMY AND PHYSIOLOGY OF THE SKIN".pdf
 
Painting Rats White Angers Them to No End
Painting Rats White Angers Them to No EndPainting Rats White Angers Them to No End
Painting Rats White Angers Them to No End
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
Toothpaste for bleeding gums and sensitive teeth. Teeth whitening, Mouthwash....
 
Pharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxPharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptx
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptx
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptx
 
The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
SCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATIONSCOPE OF CRITICAL CARE ORGANIZATION
SCOPE OF CRITICAL CARE ORGANIZATION
 
Annual Training
Annual TrainingAnnual Training
Annual Training
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal Tutor
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
Understanding Warts and Moles: Differences, Types, and Common Locations
Understanding Warts and Moles: Differences, Types, and Common LocationsUnderstanding Warts and Moles: Differences, Types, and Common Locations
Understanding Warts and Moles: Differences, Types, and Common Locations
 

Swine Flu 2017

  • 2. CONTENT What is Swine flu? Symptoms of Swine flu? Mode of Transmission ? Period of Communicability? Incubation Period? Prevention of Swine flu TAKE HOME MESSAGE
  • 3. WHAT IS SWINE FLU? It is a respiratory disease caused by H1 N1 Type A Influenza Virus. It is like ordinary flu. The Swine flu was initially seen in humans in Mexico in 2009, where the strand of the particular virus was a marriage of 3 types of strands.
  • 6. WHAT IS SWINE FLU?  The major reason of its world wide spread is the lack of immunity against the virus in a large population. WHO declares swine flu as pandemic on 11 June 2009.
  • 8. SYMPTOMS OF SWINE FLU?  Fever  Sore Throat  Cough  Headache  Body ache  Lethargy  Diarrhoea and Vomiting
  • 10. Mode of Transmission?  Cough and Sneezing by Infected Indl  Virus deposited on any Surface  Healthy indl touches the contaminated surface  Healthy Indl touches his Eyes, Nose or Mouth  Healthy Indl becomes infected
  • 13. High Risk Group  Children with mild illness but with predisposing risk factors.  Pregnant women;  Persons aged 65 years or older;  Patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS;  Patients on long term cortisone therapy.
  • 14. Warning Signals in Adults ?  Breathlessness,  chest pain,  drowsiness,  fall in blood pressure,  sputum mixed with blood,  bluish discolouration of nails;  Confusion
  • 15. Warning Signals in Children (Red Flag Signs) ?  Somnolence,  high and persistent fever,  inability to feed well,  convulsions,  shortness of breath,  difficulty in breathing,  Inconsolable cry, etc.
  • 16. Prevention and control  In order to prevent and contain outbreak of Influenza virus the following guidelines for screening, testing and isolation are to be followed:  At first all individuals seeking consultations for flu like symptoms should be screened at healthcare facilities both Government and private or examined by a doctor and these will be categorized as under:
  • 17. Category A  Patients with mild fever plus cough / sore throat with or without bodyache, headache, diarrhoea and vomiting will be categorized as Category-A.  They do not require Oseltamivir and should be treated for the symptoms mentioned above. The patients should be monitored for their progress and reassessed at 24 to 48 hours by the doctor.  No testing of the patient for Influenza is required.  Patients should confine themselves at home and avoid mixing up with public and high risk members in the family.
  • 18. Category B  (i) In addition to all the signs and symptoms mentioned under Category-A, if the patient has high grade fever and severe sore throat, may require home isolation and Oseltamivir;  (ii) In addition to all the signs and symptoms mentioned under Category-A, individuals having one or more of the following high risk conditions shall be treated with Oseltamivir:
  • 19. Category B  Children with mild illness but with predisposing risk factors.  Pregnant women;  Persons aged 65 years or older;  Patients with lung diseases, heart disease, liver disease, kidney disease, blood disorders, diabetes, neurological disorders, cancer and HIV/AIDS;  Patients on long term cortisone therapy
  • 20. Category B  No tests for Influenza is required for Category-B (i) and (ii).  All patients of Category-B (i) and (ii) should confine themselves at home and avoid mixing with public and high risk members in the family.  Broad Spectrum antibiotics as per the Guideline for Community-acquired pneumonia (CAP) may be prescribed.
  • 21. Category C  In addition to the above signs and symptoms of Category-A and B, if the patient has one or more of the following:  Breathlessness, chest pain, drowsiness, fall in blood pressure, sputum mixed with blood, bluish discolouration of nails;
  • 22. Category C  Children with influenza like illness who had a severe disease as manifested by the red flag signs (Somnolence, high and persistent fever, inability to feed well, convulsions, shortness of breath, difficulty in breathing, etc).  Worsening of underlying chronic conditions.  All these patients mentioned above in Category-C require testing, immediate hospitalization and treatment.
  • 24. रोकथाम के उपाय क्या करैं १. ख ांसते य छ ांकते समय अपने मांह व न क को टिश्यू य रूम ल से कवर करैं | २. अपनी आांख, न क य मांह को छू ने से पहले ह थों को अच्छ तरह स बन से धोयें | ३. बीम र व्यक्तत से दूरी बन ये रखें | ४. कोई भी तकलीफ होने पर डॉतिर की सल ह अवश्य लें | ५. खूब प नी पीयें, पोषक भोजन ख यें और भरपूर नीांद लें | क्या नह ीं करैं १.ह थ ममल ने, गले ममलने और चम्बन लेने से बचें | २. भीड़ व ले स्थ नों पर ज ने से बचें | ३. फ्लू रोगी के अधधक ननकि न ज यें | ४. जह ाँ तक हो सके अपनी आाँख, न क य मांह को न छयें | ५. अपने ह थों पर ख ांसे य छ कें नहीां ६. ड तिर की सल ह के बबन कोई दव ई न लें |
  • 25. Vaccine  While declaring the Pandemic to be over in August 2010, WHO conveyed that Pandemic Influenza A (HINI) virus that caused Pandemic [2009-2010] would circulate as Seasonal Influenza virus and would continue to do so for years to come.  WHO recommended vaccine only for High Risk Group  Ministry of Health and Family Welfare recommends the trivalent inactivated influenza vaccine.
  • 26. Vaccine  The ICMR has recommended on the following Seasonal Influenza vaccine composition, for the period 2017-2018. The recommended Trivalent vaccine should have:  an A/Michigan/45/2015 (H1N1)pdm09-like virus  an A/Hong Kong/4801/2014 (H3N2) – like virus  a B/Brisbane/60/2008-like virus
  • 27. Vaccine  The available vaccine takes about 2-3 weeks for development of immunity. Hence for the health care workers working in an environment with likelihood of exposure to Influenza virus, vaccine should be administered at least one month prior to the commencement of the season, till such time use of chemoprophylaxis may be considered.
  • 28. Vaccine  The available vaccine takes about 2-3 weeks for development of immunity. Hence for the health care workers working in an environment with likelihood of exposure to Influenza virus, vaccine should be administered at least one month prior to the commencement of the season, till such time use of chemoprophylaxis may be considered.
  • 29. Limitations of the Influenza Vaccination  Influenza vaccination is most effective when circulating viruses are well-matched with vaccine viruses.  Even with appropriate matching, efficacy of vaccine may be about 70% to 80%.  In case the locally circulating virus is different from vaccine virus recommended by WHO, it may be partially effective or not be effective at all.  Hence, vaccine should not give a false sense of security.
  • 30. High Risk Groups for whom vaccine is recommended by WHO  Health Care workers, working in hospital / institutional settings (doctors, nurses, paramedics) with likelihood of exposure to Influenza virus  Young children  Pregnant women;  Persons aged 65 years or older;  Patients with Comorbidity  Patients with compromised immunity
  • 31. USE OF MASKS  There are two types of masks which are recommended for various categories of personnel depending upon the work environment; 1. Triple layer surgical mask 2. N 95 Respirator  Change the mask after six hours or as soon as they become wet.  Disposable masks are never to be reused and should be disposed off.  Never touch the potentially infected outer surface of the mask while removing it.
  • 32. USE OF MASKS  There is no scientific evidence to show health benefit of using masks for members of public. In fact erroneous use of masks or continuous use of a disposable mask for longer than 6 hours or repeated use of same mask may actually increase risk of infection further.  In the hospital setting used masks should be disposed off in the identified infectious waste disposal bag/container.  In community settings, it may be disposed off either by burning or deep burial.
  • 33. Triple layer surgical mask  Suspect/ probable/confirmed cases of influenza.  The care provider in home care settings  Close family contacts of such cases undergoing home care should also use Triple layer surgical mask.  All medical personnel (Doctor, nursing and paramedical staff) would use Disposable Triple layer surgical mask while interacting with patients in screening area.  All patients, Medical and nursing staff in the isolation wards.
  • 34. Triple layer surgical mask  Personnel involved in handling dead bodies of suspect/confirmed cases (Mortuary)  Ambulance Staff including driver.  Doctors /Private practitioners with other health workers in screening centres / general practice  Health workers involved in community surveillance  Security personnel working in an infected/ potentially infected area for example Influenza ward in a hospital, screening centre etc.
  • 35. N 95 Respirator  Staff involved in any aerosol generating procedures like suction, intubation, nebulization, etc. they must use N95 Respirator  Medical personnel need to collect clinical samples from patients.  Medical personnel in ICU  Medical personnel in laboratory
  • 36. Tamiflu (Oseltamivir)  Oseltamivir is the recommended drug for treatment. Dose for treatment is as follows -  By Weight:  o For weight <15kg 30 mg BD for 5 days  o 15-23kg 45 mg BD for 5 days  o 24-<40kg 60 mg BD for 5 days  o >40kg 75 mg BD for 5 days
  • 37. Tamiflu (Oseltamivir)  For infants:  o < 3 months 12 mg BD for 5 days  o 3-5 months 20 mg BD for 5 days  o 6-11 months 25 mg BD for 5 days  It is also available as syrup (12mg per ml)
  • 38. Q 1. SWINE FLU IS CAUSED BY ? A. BACTERIA B. VIRUS C. (FUNGUS D. CONTAMINATED WATER
  • 39. Q 1. SWINE FLU IS CAUSED BY ? B. VIRUS
  • 40. Q 2. SWINE FLU SPREAD INCREASES IN ? A. Winters B. Summers C. Rain D. Spring
  • 41. Q 2. SWINE FLU SPREAD INCREASES IN ? Winters & Rainy season
  • 42. Q3. DRUG USED IN SWINE FLU TREATMENT? A. AMIKACIN B. TAMIFLU (OSELTAMIVIR) C. CETRIZINE D. GLICLAZIDE
  • 43. Q3. DRUG USED IN SWINE FLU TREATMENT ? B. TAMIFLU
  • 44. Q4. SYMPTOMS OF SWINE FLU ARE ? A.Fever B.Sore throat C.Cough D. Body ache E. All of the above
  • 45. Q4. SYMPTOMS OF SWINE FLU ARE ? E. All of the above
  • 46. Q5. What are the preventive measures of Swine flu ? A. Cover your cough and sneeze. B. Wash your hands at regular interval. C. Avoid touching your eye, nose and mouth unnecessarily. D. Keep safe distance from an infected individual. E. All of the above.
  • 47. Q5. What are the preventive measures of Swine flu ? E. All of the above

Hinweis der Redaktion

  1. Prepared on 04 March 2015
  2. Triple Layer Surgical Mask- Tie on Mask of Non-woven, Hypoallergenic 3 ply construction with filter in between offering >99 percent standard with 4 tie strings. N-95 Respirator Mask - Filter efficiency of 95 % or more against particulate aerosols. The mask should be provided with expiration valve. It should be disposable & to be able to fit for wide range of face sizes. It should accompany with certification from NIOSH (National Institute for Occupational Safety and Health) or any other internationally accepted certification.